CGEM R&D Expense Growth
Cullinan Therapeutics Inc · R&D Expense Growth
CGEM R&D Expense Growth
Latest reported31.14%period ending
CGEM FY R&D Growth (YoY) (0.00% → 31.14%)
Latest values, visible window
High-resolution chart · PNG
CGEM r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 31.1393% | |
| -3.5456% | |
| 61.1302% | |
| 59.2146% | |
| 33.6488% | |
| 157.3922% | |
| 75.1669% | |
| 0% |